News Archive

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces that one of its clients, EKF Diagnostics, won the Best Use of AIM Award at this year's AIM Awards Dinner. The AIM Awards highlight those companies listed on the London Stock Exchange's Alternative Investment Market that have stood out as the stars over the last 12 months.

EKF Diagnostics is a worldwide manufacturer of point of care in-vitro diagnostics devices and has been a client of Walbrook since March 2010. The organisers of the Awards describe the winner of the Best Use of AIM Awards as being "a company that regards its arrival on AIM as the beginning of a journey rather than a destination in itself. The winning company will probably have raised money initially from a wide spread of institutional and private investors and may well have undertaken further fund raisings to accelerate its growth."